Phenylpropanolamine Hydrochloride

Verify with FDA CVM →

884 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
884
Total Reports
31
Deaths Reported
350.0%
Death Rate

Active Ingredients

Phenylpropanolamine Hydrochloride

Administration Routes

OralUnknownOther

Species Affected

Dog 824
Unknown 55
Human 2
Other 2
Dormouse 1

Most Affected Breeds

Retriever - Labrador 109
Unknown 67
Shepherd Dog - German 59
Dog (unknown) 36
Crossbred Canine/dog 35
Boxer (German Boxer) 35
Pit Bull 31
Doberman Pinscher 25
Collie - Border 24
Siberian Husky 22

Most Reported Reactions

Lack of efficacy - NOS 291
Vomiting 141
Panting 101
Diarrhoea 85
Lethargy (see also Central nervous system depression in 'Neurological') 67
Emesis (multiple) 60
Behavioural disorder NOS 48
Anorexia 43
Lethargy (see also Central nervous system depression in Neurological) 43
Restlessness 37
Agitation 36
Underfilling, Package 32

Outcome Breakdown

Outcome Unknown
393 (47.3%)
Recovered/Normal
338 (40.7%)
Ongoing
59 (7.1%)
Euthanized
18 (2.2%)
Died
13 (1.6%)
Recovered with Sequela
9 (1.1%)

Data Summary

Metric Value
Total adverse event reports 884
Reports involving death 31
Case-fatality rate (reported events) 350.0%
Distinct species in reports 5
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Phenylpropanolamine Hydrochloride Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 884 adverse event reports referencing Phenylpropanolamine Hydrochloride, including 31 reports in which the animal died — a 350.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Phenylpropanolamine Hydrochloride. Reported administration routes include Oral, Unknown, Other. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Phenylpropanolamine Hydrochloride reports are Dog (824 reports), Unknown (55 reports), Human (2 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (109), Unknown (67), Shepherd Dog - German (59) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Phenylpropanolamine Hydrochloride are Lack of efficacy - NOS (291), Vomiting (141), Panting (101), Diarrhoea (85). Of the 830 reports with a coded outcome, Outcome Unknown is the leading category at 47.3%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Phenylpropanolamine Hydrochloride.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial